Round J, Kirwin E, van Katwyck S, McCabe C. Improving Transparency of Decision Models Through the Application of Decision Analytic Models with Omitted Objects Displayed (DAMWOOD). 2024. Pharmacoeconomics. 

Rafferty E, Unsal A, Kirwin E. Healthcare Costs and Effects of Post-COVID-19 Condition in Canada. 2023. Canada Communicable Disease Report. 

Akpinar I, Kirwin E, Chojecki D, Tjosvold L, Round J. A systematic review of the accessibility, acceptability, safety, efficiency, clinical effectiveness and cost- effectiveness of private providers of elective surgical services compared with public providers. 2023. International Journal of Health Technology Assessment.

Kirwin E, Meacock R, Round J, Sutton M. The Diagonal Approach: A theoretic framework for the economic evaluation of vertical and horizontal interventions in healthcare.  2022. Social Science & Medicine. 

Kirwin E, Bond K, Round J, McCabe C. A Conceptual Framework for Life-Cycle Health Technology Assessment.  2022. Value in Health.

Kirwin E, Rafferty E, Harback K, Round J, McCabe C. A Net Benefit Approach for the Optimal Allocation of a COVID-19 Vaccine. 2021. PharmacoEconomics.

Mulberry N, Tupper P, Kirwin E, McCabe C, Colijn C. Vaccine rollout strategies: The case for vaccinating essential workers early. 2021. PLOS Global Public Health.

Briggs A, Goldstein D, Kirwin E, Meacock R, Pandya A, Vanness D, Wisloff T. Estimating (quality-adjusted) life-year losses associated with deaths: with application to COVID-19. 2020. Health Economics. 

Kirwin E, Varughese M, Waldner D, Simmonds K, Joffe A, Smith S. Incremental Inpatient Cost Due to Methicillin-Resistant Staphylococcus aureus in Alberta, Canada. 2019. BMC Health Services Research. 

Barichello S, Nguyen T, Lu D, Ismond K, Loomes D, Kirwin E, Wang H, Chang D, Svenson L, Fedorak R. Comparative Effectiveness and Cost-Effectiveness Analysis of a Urine Test versus Alternative Colorectal Cancer Screening Strategies. 2018. American Journal of Gastroenterology.

Beilman C, Kirwin E, Ma C, McCabe C, Fedorak R, Halloran B. Early Initiation of Anti-TNF Therapy is Cost-Saving Compared to Late Initiation for Patients with Chrohn’s Disease. 2017. Clinical Gastroenterology & Hepatology. 

Dover D, Kirwin E, Hernandez N, Nelson K. Pandemic Risk Assessment Model (PRAM): A Mathematical Modeling Approach to Pandemic Influenza Planning. 2016. Epidemiology and Infection.